Breaking News Instant updates and real-time market news.

2020-09-15 07:41:40 PCRX Pacira $58.26 / +0.78 (+1.36%) 07:41 09/15/20 09/15 07:41 09/15/20 07:41	IPG, Pacira collaborate to reduce postsurgical opioid prescribing costs IPG and Pacira BioSciences announced a collaboration to reduce postsurgical opioid prescribing and surgical procedure costs across the IPG national health plan and provider network. Through this partnership, IPG will offer reimbursement for EXPAREL to its health plan provider clients across the country to further support its mission to bring high quality, cost-effective surgical solutions to the U.S. healthcare market. Pacira will work alongside IPG to provide education and training to ensure consistent, positive outcomes are achieved across procedures, clinicians, and provider facilities. Under the terms of the partnership, the organizations will co-develop clinician-facing educational materials and EXPAREL resources that will support best practice pain management for surgical patients.	22 Mar
PCRX Pacira $58.26 / +0.78 (+1.36%) 08/14/20 Truist Pacira price target raised to $65 from $54 at Truist 08/10/20 H.C. Wainwright Pacira price target raised to $70 from $68 at H.C. Wainwright 07/13/20 H.C. Wainwright Pacira price target raised to $68 from $63 at H.C. Wainwright 07/10/20 Jefferies Pacira price target raised to $69 from $53 at Jefferies

2020-09-15 07:41:40

PCRX

Pacira

$58.26 / +0.78 (+1.36%)

07:41

09/15/20

09/15

07:41

09/15/20

07:41

IPG, Pacira collaborate to reduce postsurgical opioid prescribing costs

IPG and Pacira BioSciences announced a collaboration to reduce postsurgical opioid prescribing and surgical procedure costs across the IPG national health plan and provider network. Through this partnership, IPG will offer reimbursement for EXPAREL to its health plan provider clients across the country to further support its mission to bring high quality, cost-effective surgical solutions to the U.S. healthcare market. Pacira will work alongside IPG to provide education and training to ensure consistent, positive outcomes are achieved across procedures, clinicians, and provider facilities. Under the terms of the partnership, the organizations will co-develop clinician-facing educational materials and EXPAREL resources that will support best practice pain management for surgical patients.

22
Mar

PCRX Pacira

$58.26 / +0.78 (+1.36%)

08/14/20 Truist: Pacira price target raised to $65 from $54 at Truist

08/10/20 H.C. Wainwright: Pacira price target raised to $70 from $68 at H.C. Wainwright

07/13/20 H.C. Wainwright: Pacira price target raised to $68 from $63 at H.C. Wainwright

07/10/20 Jefferies: Pacira price target raised to $69 from $53 at Jefferies

TODAY'S FREE FLY STORIES

Upgrade	Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility » 07:11 04/13/21 04/13 07:11 04/13/21 07:11 BMY Bristol-Myers $62.70 / +0.09 (+0.14%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 04/11/21 Bristol-Myers announces results from CheckMate -816 study 04/08/21 Bristol-Myers reports 'positive' results from Phase 3 CheckMate -648 trial 04/01/21 Agios Pharmaceuticals enters agreement to repurchase stock from Bristol-Myers 03/30/21 Huyabio International enters clinical collaboration agreement with Bristol-Myers BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 06:08 Today Truist Bristol-Myers upgraded to Buy from Hold at Truist 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 03/08/21 BofA Gartner added to US 1 List, Bristol-Myers removed at BofA 02/12/21 Morgan Stanley Amgen court decision may have readthrough for Gilead, says Morgan Stanley BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 11/21/20 Week in review: How Trump's policies moved stocks 04/29/21 Bristol-Myers - BMY 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 01/28/22 PDUFA Date for Mavacamten 05/04/21 Bristol Myers Squibb Co BMY Bristol-Myers $62.70 / +0.09 (+0.14%) 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish
Recommendations	TripAdvisor price target raised to $29 from $24 at Jefferies » 07:10 04/13/21 04/13 07:10 04/13/21 07:10 TRIP TripAdvisor $51.17 / -1.27 (-2.42%) Jefferies analyst Brent… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 03/24/21 TripAdvisor, Reckitt announce partnership 03/22/21 TripAdvisor announces $300M convertible notes offering 02/18/21 TripAdvisor sees Q1 revenue, adjusted EBITDA roughly in line with 4Q20 02/18/21 TripAdvisor: January revenue performance dipped slightly relative to December TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 04/05/21 Evercore ISI TripAdvisor assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research TripAdvisor initiated with a Peer Perform at Wolfe Research 03/12/21 Truist TripAdvisor price target raised to $62 from $48 at Truist 03/02/21 Citi TripAdvisor upgraded to Buy from Neutral at Citi TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 02/18/21 TripAdvisor reports Q4 adjusted EPS (41c), consensus (25c) 02/18/21 Notable companies reporting after market close 11/06/20 TripAdvisor expects Q4 revenue to be modestly lower than Q3, consensus $174.93M 11/05/20 TripAdvisor reports Q3 adjusted EPS (17c), consensus (26c) TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 01/08/21 Another Tesla upgrade among today's top calls on Wall Street 12/02/20 Fly Intel: Pre-market Movers TRIP TripAdvisor $51.17 / -1.27 (-2.42%) 03/24/21 Unusually active option classes on open March 24th 03/05/21 Unusually active option classes on open March 5th 03/03/21 TripAdvisor call volume above normal and directionally bullish 02/26/21 TripAdvisor call volume above normal and directionally bullish
Hot Stocks	Bausch Health eye health business announces GOBI trial meets all endpoints » 07:10 04/13/21 04/13 07:10 04/13/21 07:10 BHC Bausch Health $29.93 / -0.86 (-2.79%) Bausch + Lomb, a global… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BHC Bausch Health $29.93 / -0.86 (-2.79%) 04/07/21 Bausch Health's ClearVisc viscosurgical device approved by FDA 03/31/21 Bausch Health to sell Amoun Pharmaceuticals to ADQ for about $740M 03/11/21 Bausch Health appoints Sam Eldessouky as CFO effective June 1 02/26/21 Bausch Health to reduce debt by $100M BHC Bausch Health $29.93 / -0.86 (-2.79%) 03/24/21 Fly Intel: Top five analyst downgrades 03/24/21 BofA BofA downgrades Bausch Health to Underperform, sees stock 'priced to perfection' 03/24/21 BofA Bausch Health downgraded to Underperform from Neutral at BofA 03/16/21 H.C. Wainwright Bausch Health price target raised to $55 from $50 at H.C. Wainwright BHC Bausch Health $29.93 / -0.86 (-2.79%) 02/24/21 Bausch Health sees FY21 revenue $8.6B-$8.8B, consensus $8.5B 02/24/21 Bausch Health reports Q4 revenue $2.21B, consensus $2.17B 01/12/21 Bausch Health sees Q4 revenue over $2.20B, consensus $2.12B 11/03/20 Bausch Health reports Q3 adjusted EBITDA $948M, consensus $844.9M BHC Bausch Health $29.93 / -0.86 (-2.79%) 12/29/20 Fly Intel: Pre-market Movers 11/03/20 Fly Intel: Pre-market Movers 05/04/21 Bausch Health - BHC BHC Bausch Health $29.93 / -0.86 (-2.79%) 03/09/21 Bausch Health call volume above normal and directionally bullish 03/03/21 Bausch Health put volume heavy and directionally bearish 01/05/21 Bausch Health call volume above normal and directionally bullish 01/04/21 Bausch Health call volume above normal and directionally bullish
Recommendations	Expedia price target raised to $175 from $145 at Jefferies » 07:10 04/13/21 04/13 07:10 04/13/21 07:10 EXPE Expedia $171.77 / -3.14 (-1.80%) Jefferies analyst Brent… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options EXPE Expedia $171.77 / -3.14 (-1.80%) 02/11/21 Expedia sees Q1 adjusted EBITDA down significantly. 02/11/21 Expedia reports Q4 room night growth down 61% 12/08/20 Porch.com appoints Matthew Cullen as general counsel, secretary 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter EXPE Expedia $171.77 / -3.14 (-1.80%) 04/05/21 Evercore ISI Expedia assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research Expedia initiated with a Peer Perform at Wolfe Research 03/30/21 Gordon Haskett Expedia initiated with a Buy at Gordon Haskett 03/25/21 Morgan Stanley Expedia price target raised to $200 from $160 at Morgan Stanley EXPE Expedia $171.77 / -3.14 (-1.80%) 02/11/21 Expedia reports Q4 adjusted EPS ($2.64), consensus ($1.97) 02/11/21 Notable companies reporting after market close 11/04/20 Expedia reports Q3 adjusted EPS (22c), consensus (79c) 11/04/20 Notable companies reporting after market close EXPE Expedia $171.77 / -3.14 (-1.80%) 04/08/21 Expedia adds tool to check Covid restrictions amid travel lust, The Verge says 11/20/20 Tech giants threaten to exit Pakistan over censorship law, TechCrunch says 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports EXPE Expedia $171.77 / -3.14 (-1.80%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/30/21 Alphabet, Roku upgrades among today's top calls on Wall Street 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday EXPE Expedia $171.77 / -3.14 (-1.80%) 04/07/21 Expedia call volume above normal and directionally bullish 02/03/21 Unusually active option classes on open February 3rd 01/25/21 Expedia call volume above normal and directionally bullish 12/16/20 Expedia call volume above normal and directionally bullish
Hot Stocks	Extreme Networks appoints John Abel as CFO » 07:10 04/13/21 04/13 07:10 04/13/21 07:10 EXTR Extreme Networks $9.47 / +0.06 (+0.64%) Extreme Networks… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 02/17/21 Extreme Networks selected by MLB as official wi-fi solutions provider 10/28/20 Extreme Networks sees Q2 adjusted gross margin 60%-60.6% EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 02/24/21 Lake Street Extreme Networks price target raised to $12 from $8 at Lake Street 02/10/21 B. Riley Securities Extreme Networks price target raised to $12.50 from $11 at B. Riley Securities 01/28/21 Lake Street Extreme Networks price target raised to $8 from $6 at Lake Street 01/28/21 B. Riley Securities Extreme Networks price target raised to $11 from $9.50 at B. Riley Securities EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 02/09/21 Extreme Networks backs Q3 adjusted EPS view 11c-16c, consensus 13c 02/09/21 Extreme Networks reports Q2 adjusted EPS 13c, consensus 14c 01/27/21 Extreme Networks sees Q2 non-GAAP EPS 11c-17c, consensus 11c 01/27/21 Extreme Networks sees Q3 non-GAAP EPS 11c-16c, consensus 8c EXTR Extreme Networks $9.47 / +0.06 (+0.64%) 01/27/21 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference

Recommendations	Nasdaq price target raised to $164 from $160 at Deutsche Bank » 07:09 04/13/21 04/13 07:09 04/13/21 07:09 NDAQ Nasdaq $156.17 / +0.15 (+0.10%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 03/16/21 PureStream Trading Technologies selects Nasdaq to power its ATS 02/08/21 Nasdaq gets Investment Canada Act approval for Verafin, acquisition 02/02/21 Tradeweb Markets to acquire Nasdaq fixed income trade platform for $190M 02/02/21 Nasdaq to sell U.S. fixed income business to Tradeweb Markets NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 04/09/21 UBS Nasdaq price target raised to $178 from $170 at UBS 04/08/21 Piper Sandler Nasdaq price target raised to $165 from $160 at Piper Sandler 01/29/21 Citi Nasdaq price target raised to $147 from $144 at Citi 01/28/21 Barclays Nasdaq price target raised to $160 from $155 at Barclays NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 01/27/21 Nasdaq reports Q4 adjusted EPS $1.60, consensus $1.45 10/21/20 Nasdaq reports Q3 adj. EPS $1.58, consensus $1.45 NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 03/05/21 Robinhood picks Nasdaq for eventual IPO, CNBC reports 02/12/21 Senate Republicans urge SEC to reject Nasdaq diversity rules, Reuters reports NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 03/05/21 Fly Intel: Wall Street's top stories for Friday 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Morgan Stanley sees needed AML fix potentially slowing Square's Cash App growth 11/19/20 Fly Intel: Wall Street's top stories at midday 04/21/21 Nasdaq - NDAQ NDAQ Nasdaq $156.17 / +0.15 (+0.10%) 12/07/20 Early notable gainers among liquid option names on December 7th
Upgrade	Booking Holdings upgraded to Buy on coming travel rebound at Jefferies » 07:09 04/13/21 04/13 07:09 04/13/21 07:09 BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 03/25/21 JetBlue announces launch of Paisly by JetBlue, a new travel website 02/24/21 Booking Holdings CEO says 'more confident than ever' in eventual travel recovery 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 11/16/20 Lone Pine buys Square, exits Visa in Q3 BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 06:48 Today Jefferies Booking Holdings upgraded to Buy from Hold at Jefferies 04/05/21 Evercore ISI Booking Holdings assumed with an In Line at Evercore ISI 03/31/21 Wolfe Research Booking Holdings initiated with an Outperform at Wolfe Research 03/30/21 Gordon Haskett Booking Holdings initiated with a Hold at Gordon Haskett BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 02/24/21 Booking Holdings reports Q4 adjusted EPS (57c), consensus ($4.28) 02/24/21 Notable companies reporting after market close 11/05/20 Booking CEO says COVID-19 surge to impact travel in near-term 11/05/20 Booking Holdings reports Q3 adjusted EPS $12.27, consensus $14.13 BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/30/21 Alphabet, Roku upgrades among today's top calls on Wall Street 03/22/21 Snap downgrade, PepsiCo upgrade among today's top calls on Wall Street 01/04/21 Airbnb under pressure as Wall Street analysts roll out coverage following IPO 05/24/21 Global Technology, Media & Communications Virtual Conference BKNG Booking Holdings $2,409.04 / -30.64 (-1.26%) 01/04/21 Booking Holdings put volume heavy and directionally bearish
Downgrade	Idacorp downgraded to Neutral from Buy at BofA » 07:08 04/13/21 04/13 07:08 04/13/21 07:08 IDA Idacorp $100.06 / +0.49 (+0.49%) BofA analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events IDA Idacorp $100.06 / +0.49 (+0.49%) 01/06/21 Wells Fargo Wells Fargo says buy CenterPoint Energy, sell FirstEnergy 01/06/21 Wells Fargo Idacorp downgraded to Underweight from Equal Weight at Wells Fargo 05/04/20 Sidoti Idacorp upgraded to Buy on valuation at Sidoti 05/04/20 Sidoti Idacorp upgraded to Buy from Neutral at Sidoti IDA Idacorp $100.06 / +0.49 (+0.49%) 02/18/21 Idacorp sees FY21 EPS $.60-$4.80, consensus $4.75 02/18/21 Idacorp reports Q4 EPS 74c, consensus 67c 04/29/21 Idacorp - IDA 05/20/21 IDACORP, Inc.
Hot Stocks	Evogene's Biomica demonstrates efficacy of BMC128 in studies » 07:08 04/13/21 04/13 07:08 04/13/21 07:08 EVGN Evogene $4.37 / -0.26 (-5.62%) Biomica, a subsidiary of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options EVGN Evogene $4.37 / -0.26 (-5.62%) 03/25/21 Evogene subsidiary, Tikun Olam-Cannbit enter pact for cannabis distribution 03/17/21 Evogene's Ag-Seed division, Plastomics enter collaborative agreement 02/24/21 Evogene subsidiary, Cannbit enter collaboration for medical cannabis products 12/29/20 Lavie Bio targets product launch for LAV311, LAV312 in 2024 EVGN Evogene $4.37 / -0.26 (-5.62%) 11/30/20 Cantor Fitzgerald Cantor Fitzgerald starts 'highly underappreciated' Evogene at Overweight 11/30/20 Cantor Fitzgerald Evogene initiated with an Overweight at Cantor Fitzgerald 04/21/21 Evogene Ltd. EVGN Evogene $4.37 / -0.26 (-5.62%) 02/03/21 new option listings on February 3rd
Recommendations	Nvidia price target raised to $575 from $560 at Deutsche Bank » 07:08 04/13/21 04/13 07:08 04/13/21 07:08 NVDA Nvidia $608.46 / +33.14 (+5.76%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Nvidia announces eight new Ampere architecture GPUs 04/12/21 Cloudera up 3% to $13.01 after announcing collaboration with Nvidia 04/12/21 Cloudera collaborates with Nvidia to accelerate data analytics, AI in the cloud 04/12/21 Nvidia unveils Nvidia Drive Atlan 'AI center on wheels' NVDA Nvidia $608.46 / +33.14 (+5.76%) 06:57 Today Mizuho Nvidia price target raised to $675 from $650 at Mizuho 06:56 Today Susquehanna Nvidia to invest heavily into data center space, says Susquehanna 06:09 Today Barclays Nvidia price target raised to $650 from $600 at Barclays 04/12/21 Lynx Intel, AMD selloffs on Nvidia 'Grace' news a buying opportunity, says Lynx NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Nvidia sees Q1 revenue tracking above $5.3B guide, consensus $5.32B 02/24/21 Nvidia sees Q1 revenue $5.3B +/- 2%, consensus $4.51B 02/24/21 Nvidia reports Q4 EPS $3.10, consensus $2.81 02/24/21 Notable companies reporting after market close NVDA Nvidia $608.46 / +33.14 (+5.76%) 03/23/21 Nintendo to use upgraded Nvidia chip in 2021 Switch model, Bloombreg reports 03/09/21 Some Xbox users can now stream Steam games through web browser, VGC says 02/12/21 Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says 02/12/21 FTC opened in-depth investigation of Nvidia's ARM deal, Bloomberg reports NVDA Nvidia $608.46 / +33.14 (+5.76%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/09/21 The Intersection: Crypto and Wall Street This Week 03/26/21 The Intersection: Crypto and Wall Street This Week 03/23/21 Game On: Microsoft in talks to buy Discord as Sony acquires EVO NVDA Nvidia $608.46 / +33.14 (+5.76%) 02/25/21 NVIDIA call buyer realizes 13% same-day gains 01/11/21 Early notable gainers among liquid option names on January 11th 11/18/20 NVIDIA options imply 8.0% move in share price post-earnings 11/04/20 NVIDIA call buyer realizes 8% same-day gains

Syndicate	Liquidia Technologies announces $21.7M private placement » 07:08 04/13/21 04/13 07:08 04/13/21 07:08 LQDA Liquidia Technologies $2.53 / -0.05 (-1.94%) Liquidia Corporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Options LQDA Liquidia Technologies $2.53 / -0.05 (-1.94%) 03/30/21 Liquidia's generic Treprostinil injection can be given subcutaneously 03/23/21 Liquidia Technologies intends to submit response to FDA CRL in mid-2021 03/23/21 Liquidia Technologies initiates actions to reduce net annual cash spending 03/02/21 Liquidia Technologies secures $20.5M debt facility with Silicon Valley Bank LQDA Liquidia Technologies $2.53 / -0.05 (-1.94%) 12/04/20 Fly Intel: Top five analyst initiations 12/04/20 H.C. Wainwright Liquidia Technologies initiated with a Buy at H.C. Wainwright 11/20/20 Fly Intel: Top five analyst downgrades 11/20/20 Wedbush Liquidia Technologies downgraded to Neutral from Outperform at Wedbush LQDA Liquidia Technologies $2.53 / -0.05 (-1.94%) 03/23/21 Liquidia Technologies reports 2020 EPS ($1.76), consensus ($1.74) 11/09/20 Liquidia Technologies reports Q3 EPS (40c), two est. (36c) 30 Jun LQDA Liquidia Technologies $2.53 / -0.05 (-1.94%) 11/03/20 Largest borrow rate increases among liquid names 10/30/20 Largest borrow rate increases among liquid names 10/28/20 Largest borrow rate increases among liquid names
Hot Stocks	Rigel announces results from Phase 2 clinical trial of fostamatinib » 07:07 04/13/21 04/13 07:07 04/13/21 07:07 RIGL Rigel Pharmaceuticals $3.10 / -0.155 (-4.77%) Rigel Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events RIGL Rigel Pharmaceuticals $3.10 / -0.155 (-4.77%) 04/07/21 Rigel Pharmaceuticals closes R552 licensing agreement with Eli Lilly 03/11/21 Rigel Pharma completes patient enrollment for Phase 2 trial of fostamatinib 02/18/21 Eli Lilly, Rigel Pharmaceuticals enter exclusive license agreement for R552 01/29/21 Rigel announces award of $16.5M from DOD for fostamatinib trial in COVID-19 RIGL Rigel Pharmaceuticals $3.10 / -0.155 (-4.77%) 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 11/09/20 Fly Intel: Top five analyst downgrades 11/09/20 JPMorgan Rigel Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan RIGL Rigel Pharmaceuticals $3.10 / -0.155 (-4.77%) 03/02/21 Rigel Pharmaceuticals reports Q4 EPS (11c), consensus (11c) 01/11/21 Rigel Pharmaceuticals sees Q4 revenue approximately $18.4M, consensus $17.81M 11/05/20 Rigel Pharmaceuticals reports Q3 EPS (8c), consensus (12c) RIGL Rigel Pharmaceuticals $3.10 / -0.155 (-4.77%) 01/15/21 Rigel looks to choke 'storm' that causes Covid patients to die, SFBT says 05/18/21 Rigel Pharmaceuticals Inc.
Hot Stocks	Castle Biosciences says DecisionDx-Melanoma is significant predictor of outcomes » 07:07 04/13/21 04/13 07:07 04/13/21 07:07 CSTL Castle Biosciences $67.54 / -1.9 (-2.74%) Castle Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly CSTL Castle Biosciences $67.54 / -1.9 (-2.74%) 01/13/21 Castle Biosciences delivered 5,157 gene expression profile test reports in Q4 12/04/20 Castle Biosciences publishes DecisionDx-Melanoma clinical use study 11/17/20 Castle Biosciences announces publication of two studies in SKIN 11/12/20 Castle Biosciences presents data for melanoma tests at ASDP CSTL Castle Biosciences $67.54 / -1.9 (-2.74%) 03/09/21 Baird Castle Biosciences price target lowered to $82 from $87 at Baird 02/03/21 KeyBanc Castle Biosciences price target raised to $90 from $70 at KeyBanc 01/26/21 Canaccord Castle Biosciences price target raised to $84 from $80 at Canaccord 01/15/21 SVB Leerink Castle Biosciences price target raised to $80 from $70 at SVB Leerink CSTL Castle Biosciences $67.54 / -1.9 (-2.74%) 03/08/21 Castle Biosciences reports Q4 EPS (23c), consensus (12c) 11/09/20 Castle Biosciences reports Q3 EPS (23c), consensus (11c) 16 Dec 25 Jun CSTL Castle Biosciences $67.54 / -1.9 (-2.74%) 03/08/21 Fly Intel: After-Hours Movers
Initiation	Truist starts Instil Bio with a Buy citing efficacy in solid tumors » 07:07 04/13/21 04/13 07:07 04/13/21 07:07 TIL Instil Bio $22.13 / +0.05 (+0.23%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly TIL Instil Bio $22.13 / +0.05 (+0.23%) 04/12/21 Instil Bio presents clinical data for metastatic melanoma at 2021 AACR meeting TIL Instil Bio $22.13 / +0.05 (+0.23%) 06:18 Today Truist Instil Bio initiated with a Buy at Truist 06:00 Today Cowen Instil Bio initiated with an Outperform at Cowen 05:59 Today Morgan Stanley Instil Bio initiated with an Equal Weight at Morgan Stanley 19 Mar TIL Instil Bio $22.13 / +0.05 (+0.23%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO
Hot Stocks	Versus Systems' adds functionality to prizing engine to support uses in India » 07:07 04/13/21 04/13 07:07 04/13/21 07:07 VRSSF Versus Systems / + Versus Systems announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<

Recommendations	HCA Healthcare price target raised to $210 from $180 at Deutsche Bank » 07:07 04/13/21 04/13 07:07 04/13/21 07:07 HCA HCA Healthcare $191.65 / +0.54 (+0.28%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events HCA HCA Healthcare $191.65 / +0.54 (+0.28%) 02/24/21 Brookdale Senior Living to sell 80% stake in BHS to HCA Healthcare for $400M 01/26/21 HCA Healthcare uses Its COVID-19 registry to aid research in area 01/21/21 HCA Healthcare in new JV with A Plus International to expand PPE access 10/26/20 HCA Healthcare sees FY21 EBITDA $10.25B-$10.65B HCA HCA Healthcare $191.65 / +0.54 (+0.28%) 04/09/21 Mizuho HCA Healthcare price target raised to $205 from $195 at Mizuho 02/05/21 Mizuho HCA Healthcare price target raised to $195 from $180 at Mizuho 02/04/21 HCA Healthcare price target raised to $203 from $164 at UBS 02/03/21 Citi HCA Healthcare price target raised to $191 from $185 at Citi HCA HCA Healthcare $191.65 / +0.54 (+0.28%) 02/02/21 HCA Healthcare sees FY21 EPS $12.10 to $13.10, consensus $11.95 02/02/21 HCA Healthcare reports Q4 EPS $4.13, consensus $3.60 10/26/20 HCA Healthcare reports Q3 ex-items EPS $1.92, consensus $2.32 10/26/20 HCA Healthcare reports Q3 EPS $1.95, consensus $2.32 HCA HCA Healthcare $191.65 / +0.54 (+0.28%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says HCA HCA Healthcare $191.65 / +0.54 (+0.28%) 02/02/21 Fly Intel: Pre-market Movers 11/14/20 Week in review: How Trump's policies moved stocks 05/24/21 Global Healthcare Virtual Conference 2021 04/22/21 HCA Healthcare - HCA 04/28/21 HCA Healthcare, Inc.
Syndicate	Bally's announces commencement of stock, tangible equity unit offerings » 07:07 04/13/21 04/13 07:07 04/13/21 07:07 BALY Bally's $60.79 / -0.885 (-1.43%) , JKPTF Gamesys Group $27.00 / + (+0.00%) Bally's Corporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BALY JKPTF BALY Bally's $60.79 / -0.885 (-1.43%) 07:05 Today Bally's to acquire Tropicana Las Vegas from Gaming and Leisure Properties 05:26 Today Bally's to combine with Gamesys Group 04/12/21 Bally's announces agreement with Sinclair Broadcast 03/25/21 Allied Esports Entertainment determines Bally's proposal superior to Element's JKPTF Gamesys Group $27.00 / + (+0.00%) 05:26 Today Bally's to combine with Gamesys Group 03/24/21 Bally's reports agreement in principle to buy Gamesys Group plc BALY JKPTF BALY Bally's $60.79 / -0.885 (-1.43%) 04/08/21 KeyBanc Bally's price target raised to $70 from $65 at KeyBanc 03/29/21 Truist Early March casino data looks 'very positive,' says Truist 03/25/21 Stifel Bally's price target raised to $75 from $70 at Stifel 03/24/21 Jefferies Gamesys Group and Bally's an 'interesting combination,' says Jefferies JKPTF Gamesys Group $27.00 / + (+0.00%) 03/24/21 Jefferies Gamesys Group and Bally's an 'interesting combination,' says Jefferies 03/16/21 Jefferies Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies 03/10/21 Berenberg Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg 03/10/21 Deutsche Bank Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank BALY BALY Bally's $60.79 / -0.885 (-1.43%) 07:03 Today Bally's sees Q1 revenue $185M, consensus $156.45M 03/04/21 Bally's reports Q4 adjusted EPS 39c, consensus (8c) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings BALY BALY Bally's $60.79 / -0.885 (-1.43%) 03/10/21 Casino companies prepare to compete for NYC-area license, NY Post reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says BALY JKPTF BALY Bally's $60.79 / -0.885 (-1.43%) 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 03/24/21 Fly Intel: Wall Street's top stories for Wednesday JKPTF Gamesys Group $27.00 / + (+0.00%) 03/24/21 Fly Intel: Wall Street's top stories for Wednesday 03/24/21 Fly Intel: Wall Street's top stories at midday 05/18/21 Bally's Corporation
Recommendations	ArcelorMittal price target raised to $36 from $30 at Deutsche Bank » 07:06 04/13/21 04/13 07:06 04/13/21 07:06 MT ArcelorMittal $28.95 / -0.02 (-0.07%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Options MT ArcelorMittal $28.95 / -0.02 (-0.07%) 04/08/21 Infosys announces collaboration with ArcelorMittal 04/01/21 Societe Generale increases shareholding in ArcelorMittal 03/17/21 Air Liquide, ArcelorMittal sign MOU to contribute to decarbonization of Dunkirk 02/11/21 ArcelorMittal CEO to become executive chairman, Aditya Mittal to succeed MT ArcelorMittal $28.95 / -0.02 (-0.07%) 04/12/21 UBS ArcelorMittal price target raised to EUR 30 from EUR 25 at UBS 04/09/21 Morgan Stanley ArcelorMittal price target raised to EUR 28.50 from EUR 28 at Morgan Stanley 03/24/21 Morgan Stanley ArcelorMittal price target raised to EUR 28 from EUR 24 at Morgan Stanley 02/22/21 Morgan Stanley ArcelorMittal price target raised to EUR 24 from EUR 23 at Morgan Stanley MT ArcelorMittal $28.95 / -0.02 (-0.07%) 11/05/20 ArcelorMittal reports Q3 EPS (21c), two estimates (17c) 12 May MT ArcelorMittal $28.95 / -0.02 (-0.07%) 03/24/21 Steel complex lobbies Biden administration on Trump tariffs, Bloomberg says MT ArcelorMittal $28.95 / -0.02 (-0.07%) 04/09/21 Unusually active option classes on open April 9th 04/08/21 Unusually active option classes on open April 8th 04/07/21 ArcelorMittal call volume above normal and directionally bullish 03/31/21 ArcelorMittal call volume above normal and directionally bullish
Hot Stocks	Bally's to acquire Tropicana Las Vegas from Gaming and Leisure Properties » 07:05 04/13/21 04/13 07:05 04/13/21 07:05 BALY Bally's $60.79 / -0.885 (-1.43%) , GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) Bally's (BALY)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events BALY GLPI BALY Bally's $60.79 / -0.885 (-1.43%) 05:26 Today Bally's to combine with Gamesys Group 04/12/21 Bally's announces agreement with Sinclair Broadcast 03/25/21 Allied Esports Entertainment determines Bally's proposal superior to Element's 03/25/21 Bally's Richmond Casino Resort selected as one of three finalists in Virginia GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) 01/07/21 Gaming and Leisure Properties promotes Steven Ladany to CDO 01/05/21 Gaming and Leisure Properties appoints Matthew Demchyk to CIO 12/15/20 Penn National to acquire Hollywood Casino Perryville from GLPI for $31.1M 12/15/20 Gaming and Leisure Properties reports sale and lease transactions BALY GLPI BALY Bally's $60.79 / -0.885 (-1.43%) 04/08/21 KeyBanc Bally's price target raised to $70 from $65 at KeyBanc 03/29/21 Truist Early March casino data looks 'very positive,' says Truist 03/25/21 Stifel Bally's price target raised to $75 from $70 at Stifel 03/24/21 Jefferies Gamesys Group and Bally's an 'interesting combination,' says Jefferies GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) 03/31/21 Mizuho Gaming and Leisure Properties initiated with a Buy at Mizuho 03/15/21 Fly Intel: Top five analyst initiations 03/15/21 KeyBanc Gaming and Leisure Properties initiated with an Overweight at KeyBanc 02/22/21 Deutsche Bank Gaming and Leisure Properties price target raised to $51 from $48 at Deutsche Bank BALY GLPI BALY Bally's $60.79 / -0.885 (-1.43%) 07:03 Today Bally's sees Q1 revenue $185M, consensus $156.45M 03/04/21 Bally's reports Q4 adjusted EPS 39c, consensus (8c) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) 02/18/21 Gaming and Leisure Properties reports Q4 FFO 85c, consensus 85c 10/27/20 Gaming and Leisure Propertiesl Partners reports Q3 FFO 89c, consensus 85c 30 Oct BALY BALY Bally's $60.79 / -0.885 (-1.43%) 03/10/21 Casino companies prepare to compete for NYC-area license, NY Post reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says BALY BALY Bally's $60.79 / -0.885 (-1.43%) 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 03/24/21 Fly Intel: Wall Street's top stories for Wednesday 04/30/21 Gaming and Leisure Properties - GLPI 05/18/21 Bally's Corporation
Hot Stocks	908 Devices appoints Michele Fournier as Chief People Officer » 07:04 04/13/21 04/13 07:04 04/13/21 07:04 MASS 908 Devices $50.85 / +1.05 (+2.11%) 908 Devices announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly MASS 908 Devices $50.85 / +1.05 (+2.11%) 04/08/21 908 Devices announces MX908 solution selected by U.S. Border Patrol 03/30/21 908 Devices awarded $25M purchase order by U.S. Army MASS 908 Devices $50.85 / +1.05 (+2.11%) 01/12/21 SVB Leerink 908 Devices initiated with an Outperform at SVB Leerink 01/12/21 Cowen Cowen starts 908 Devices at Outperform, sees 'mass-ive opportunity' 01/12/21 William Blair 908 Devices initiated with an Outperform at William Blair 01/12/21 SVB Leerink 908 Devices initiated with an Outperform at SVB Leerink MASS 908 Devices $50.85 / +1.05 (+2.11%) 03/30/21 908 Devices sees 2021 revenue $38M-$40M, consensus $39.19M 03/30/21 908 Devices reports Q4 EPS ($1.48), consensus (16c) 18 Dec MASS 908 Devices $50.85 / +1.05 (+2.11%) 12/20/20 Opening Day: Upstart, Wish make trading debuts

Downgrade	StoneCo assumed with a Neutral from Buy at Citi » 07:04 04/13/21 04/13 07:04 04/13/21 07:04 STNE StoneCo $67.72 / -0.05 (-0.07%) Citi analyst Gabriel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options STNE StoneCo $67.72 / -0.05 (-0.07%) 01/14/21 StoneCo raises funding for credit solution for SMBs in Brazil 11/17/20 StoneCo raises cash portion of consideration for Linx by R$1.50 per share 11/16/20 Lone Pine buys Square, exits Visa in Q3 10/29/20 StoneCo waives certain breakup fees, increases cash portion in Linx combination STNE StoneCo $67.72 / -0.05 (-0.07%) 03/17/21 Grupo Santander StoneCo upgraded to Hold from Underperform at Grupo Santander 03/12/21 HSBC StoneCo upgraded to Buy from Hold at HSBC 02/05/21 Credit Suisse StoneCo upgraded to Outperform from Neutral at Credit Suisse 01/29/21 Fly Intel: Top five analyst initiations STNE StoneCo $67.72 / -0.05 (-0.07%) 03/11/21 StoneCo reports Q4 adjusted EPS R$1.16 vs. R$0.97 last year 10/29/20 StoneCo reports Q3 adj. EPS R$0.99 vs. R$0.71 last year 13 Aug STNE StoneCo $67.72 / -0.05 (-0.07%) 03/11/21 Fly Intel: After-Hours Movers 10/29/20 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference STNE StoneCo $67.72 / -0.05 (-0.07%) 04/12/21 StoneCo put volume heavy and directionally bearish 01/20/21 Unusual call flow in option market yesterday 01/19/21 Stone cold call seller in StoneCo
Hot Stocks	Apellis provides 24-month update from phase 1b study of pegcetacoplan » 07:03 04/13/21 04/13 07:03 04/13/21 07:03 APLS Apellis $41.60 / +0.08 (+0.19%) Apellis announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events APLS Apellis $41.60 / +0.08 (+0.19%) 03/17/21 Apellis discloses NEJM study demonstrating pegcetacoplan superiority in PNH 03/04/21 Apellis to discontinue development of APL-9 following DMC review 01/21/21 Apellis says 'on track' for Phase 3 GA results in 3Q21 12/10/20 Swedish Orphan Biovitrum, Apellis report results from PEGASUS study APLS Apellis $41.60 / +0.08 (+0.19%) 03/29/21 JPMorgan Apellis added to Analyst Focus List with $87 target at JPMorgan 01/29/21 Baird Apellis assumed at Outperform at Baird 12/14/20 Roth Capital Apellis price target raised to $73 from $50 at Roth Capital 12/10/20 Cowen Apellis price target raised to $55 from $45 at Cowen APLS Apellis $41.60 / +0.08 (+0.19%) 02/25/21 Apellis reports Q EPS 93c, consensus (75c) 11/02/20 Apellis reports Q3 EPS ($1.79), consensus ($1.58) APLS Apellis $41.60 / +0.08 (+0.19%) 12/14/20 Fly Intel: Wall Street's top stories for Monday 12/14/20 Fly Intel: Wall Street's top stories at midday 05/14/21 PDUFA Date for Pegcetacoplan
Earnings	Bally's sees Q1 revenue $185M, consensus $156.45M » 07:03 04/13/21 04/13 07:03 04/13/21 07:03 BALY Bally's $60.79 / -0.885 (-1.43%) Bally's announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BALY Bally's $60.79 / -0.885 (-1.43%) 05:26 Today Bally's to combine with Gamesys Group 04/12/21 Bally's announces agreement with Sinclair Broadcast 03/25/21 Allied Esports Entertainment determines Bally's proposal superior to Element's 03/25/21 Bally's Richmond Casino Resort selected as one of three finalists in Virginia BALY Bally's $60.79 / -0.885 (-1.43%) 04/08/21 KeyBanc Bally's price target raised to $70 from $65 at KeyBanc 03/29/21 Truist Early March casino data looks 'very positive,' says Truist 03/25/21 Stifel Bally's price target raised to $75 from $70 at Stifel 03/24/21 Jefferies Gamesys Group and Bally's an 'interesting combination,' says Jefferies BALY Bally's $60.79 / -0.885 (-1.43%) 03/04/21 Bally's reports Q4 adjusted EPS 39c, consensus (8c) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings BALY Bally's $60.79 / -0.885 (-1.43%) 03/10/21 Casino companies prepare to compete for NYC-area license, NY Post reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says BALY Bally's $60.79 / -0.885 (-1.43%) 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 03/24/21 Fly Intel: Wall Street's top stories for Wednesday 05/18/21 Bally's Corporation
Hot Stocks	Becton Dickinson announces BD MAX MDR-TB assay recognized for accuracy by WHO » 07:03 04/13/21 04/13 07:03 04/13/21 07:03 BDX Becton Dickinson $247.33 / -0.6 (-0.24%) Becton Dickinson… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events BDX Becton Dickinson $247.33 / -0.6 (-0.24%) 04/07/21 Inogen appoints George Parr as Chief Commercial Officer 04/01/21 Becton Dickinson to invest $65M to construct Arizona supply chain facility 04/01/21 Becton Dickinson receives EUA from FDA for rapid antigen test 03/30/21 Becton Dickinson granted EUA from FDA for SARS-CoV-2 & Flu A+B assay BDX Becton Dickinson $247.33 / -0.6 (-0.24%) 04/05/21 Argus Weaker demand for Covid testing solutions to weigh on BD, says Argus 04/01/21 Piper Sandler Integra to benefit from FDA safety communication, says Piper Sandler 02/12/21 Wells Fargo Wells Fargo sees only 'small chance' of positive FDA panel for Becton 02/05/21 Citi Becton Dickinson price target raised to $280 from $273 at Citi BDX Becton Dickinson $247.33 / -0.6 (-0.24%) 02/04/21 Becton Dickinson raises FY21 adj. EPS view to $12.75-$12.85 from $12.40-$12.60 02/04/21 Becton Dickinson reports Q1 adjusted EPS $4.55, consensus $3.11 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open 21 May BDX Becton Dickinson $247.33 / -0.6 (-0.24%) 02/04/21 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021 05/06/21 Becton Dickinson - BDX
Earnings	Danaher sees Q1 core revenue growth 'above high-end' of prior guidance » 07:02 04/13/21 04/13 07:02 04/13/21 07:02 DHR Danaher $234.88 / +2.59 (+1.11%) Q1 consensus $6.13B.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events Options DHR Danaher $234.88 / +2.59 (+1.11%) 03/23/21 Beckman Coulter receives Emergency Use Authorization for antibody test 03/11/21 Danaher not seeing decline in Covid testing business 03/02/21 Director of Danaher Mitchell Rales purchases $1.4M in shares 01/13/21 Danaher expects Q4 revenue up approx. 38.5% y-o-y, consensus $6.44B DHR Danaher $234.88 / +2.59 (+1.11%) 04/08/21 Citi Citi opens 'positive catalyst watch' on Danaher, sees Q1 beat 04/07/21 Baird Danaher assumed with an Outperform at Baird 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance 03/02/21 Barclays Danaher started at Overweight at Barclays on GE biopharma business potential DHR Danaher $234.88 / +2.59 (+1.11%) 01/28/21 Danaher reports Q4 non-GAAP EPS $2.08, consensus $1.87 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 10/22/20 Danaher reports Q3 adj. EPS 1.72, consensus $1.36 08 May DHR Danaher $234.88 / +2.59 (+1.11%) 03/26/21 Danaher, Fortive interested in joint bid for Renishaw, Bloomberg reports 03/26/21 Danaher said to mull joint bid with Fortive for Renishaw, Bloomberg says 04/22/21 Danaher - DHR 05/05/21 Danaher Corporation DHR Danaher $234.88 / +2.59 (+1.11%) 01/22/21 Early notable gainers among liquid option names on January 22nd

Events

Earnings calls, analyst events, roadshows and more

IMCR
Today at 07:30

Immunocore - IMCR Conference Calls
BFRA
Today at 08:00

Biofrontera - BFRA Conference Calls
OGI
Today at 08:00

Organigram - OGI Conference Calls
EARS
Today at 08:00

Auris Medical - EARS Conference Calls
Today at 08:30

CPI Ex-Food & Energy M/M: March 2021 Government Event
Today at 08:30

CPI Ex Food & Energy Y/Y: March 2021 Government Event
Today at 08:30

Consumer Price Index M/M: March 2021 Government Event
Today at 08:30

Consumer Price Index Y/Y: March 2021 Government Event
KKR
Today at 08:30

KKR & Co. Inc. Firm Sponsored Meetings
Today at 08:55

Redbook Store Sales Y/Y: 4/10/21 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank $35.10 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares
Fri	No deals

View All Syndicate Announcements »

IPG, Pacira collaborate to reduce postsurgical opioid prescribing costs

TODAY'S FREE FLY STORIES

Get Full Fly Access